Tuberculosis remains the second most significant cause of infectious death after COVID-19. In 2022, 10.6 million cases and 1.3 million deaths were recorded. MDR-TB poses a serious threat due to the high incidence of resistant mycobacteria. The aim of this study was to investigate the incidence, demographic characteristics, and key clinical characteristics of patients with MDR-TB in the Bukhara and Navoi regions of the Republic of Uzbekistan.

Abduganieva E. A., Khalmukhammedova S. M., Dadabaeva R. K. The impact of lifestyle and nutritional changes on the quality of life of patients with COPD // In the collection: Features of the formation of a healthy lifestyle: factors and conditions. - 2015.

Global tuberculosis report 2023. Geneva : World Health Organization; 2023.

Usmonov I.Kh. , Muazzamov BR, Jumaev MF Features of Diagnostics and Treatment of Drug-Resistant Forms of Pulmonary Tuberculosis . International Journal of Pharmaceutical Research. 2020;12(3).

Usmonov I.Kh . Clinical Course and Modern Diagnosis of Resistant Forms of Pulmonary Tuberculosis . American Journal of Social and Humanitarian Research. 2022;3:250–260.

Ergeshov AE, Punga VV, Rusakova LI, et al . Multidrug- and extensively drug-resistant tuberculosis in the Russian Federation. Avicenna Bulletin. 2018.

Tabernero Huguet E. Advances and Challenges in Multidrug-Resistant Tuberculosis Control. Open Respiratory Archives . 2024;6(3):100333.

Gu P., Lu P., Ding H., et al . Efficiency , cost , and safety of four WHO- recommended regimens for RR/MDR-TB. Annals of Medicine . 2024;56(1):2344821.